Stockley's Drug Interactions

Stockley's Drug Interactions, edited by Claire L Preston, remains the world's most comprehensive and authoritative international reference book on drug interactions. Based upon thousands of published papers and reports this eleventh edition: - Covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, and drugs of abuse - Contains in-depth yet concise monographs in an easy-to-read format - Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance, and clear guidance on managing the interaction in practice - Has a brief summary of the interaction in each monograph - perfect for the busy healthcare professional - Is fully referenced throughout - Contains almost 4500 monographs - Is global in coverage - inclusion of drugs used worldwide New in the 11th edition: - Over 350 new monographs added - Many existing monographs have been reviewed, revalidated, and updated - A comprehensive update and restructure of the chapter on - Antidiabetic drugs, in-line with published literature - Addition of new advice regarding the concurrent use of aliskiren, - ACE inhibitors, and angiotensin-II receptor antagonists - An updated list of drugs that have a risk of prolonging the QT interval - The addition of new drugs, including apixaban, apremilast, dolutegravir, lomitapide, mirabegron, the NS5A inhibitors (daclatasvir, ledipasvir, ombitasvir), the NS5B inhibitors (dasabuvir, sofosbuvir), the sodium-glucose co-transporter-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin), and telavancin